A recent bioinformatics study identified CD48 as a candidate diagnostic biomarker for acute myocardial infarction (AMI), highlighting its potential utility in early diagnosis and risk stratification (Jin et al., 2024). The gene discussed is CD48; the disease is myocardial infarction.